NDC00015-0505-41: CYCLOPHOSPHAMIDE FOR INJECTION.
The CYCLOPHOSPHAMIDE FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, special_features: 45 MG SODIUM CHLORIDE PER 100 MG CYCLOPHOSPHAMIDE, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 1.000 GRAMS G, active_medicament_medicinal_strength: 1.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT G. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-158-7889, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| special_features | 45 MG SODIUM CHLORIDE PER 100 MG CYCLOPHOSPHAMIDE |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 1.000 GRAMS G |
| active_medicament_medicinal_strength | 1.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT G |
| NSN | 6505-01-158-7889 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 GRAMS G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | 45 MG SODIUM CHLORIDE PER 100 MG CYCLOPHOSPHAMIDE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT G |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |